ES525136A0 - Un metodo para inhibir la mineralizacion de un tejido natural - Google Patents

Un metodo para inhibir la mineralizacion de un tejido natural

Info

Publication number
ES525136A0
ES525136A0 ES525136A ES525136A ES525136A0 ES 525136 A0 ES525136 A0 ES 525136A0 ES 525136 A ES525136 A ES 525136A ES 525136 A ES525136 A ES 525136A ES 525136 A0 ES525136 A0 ES 525136A0
Authority
ES
Spain
Prior art keywords
mineralization
inhibit
natural tissue
tissue
natural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES525136A
Other languages
English (en)
Other versions
ES8600062A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Extracorporeal Medical Specialties Inc
Original Assignee
Extracorporeal Medical Specialties Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23627945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES525136(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Extracorporeal Medical Specialties Inc filed Critical Extracorporeal Medical Specialties Inc
Publication of ES525136A0 publication Critical patent/ES525136A0/es
Publication of ES8600062A1 publication Critical patent/ES8600062A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/02—Treatment of implants to prevent calcification or mineralisation in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/915—Method or apparatus for preparing biological material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/915—Method or apparatus for preparing biological material
    • Y10S623/916—Blood vessel

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Prostheses (AREA)
ES525136A 1982-08-25 1983-08-24 Un metodo para inhibir la mineralizacion de un tejido natural Expired ES8600062A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/411,190 US4405327A (en) 1982-08-25 1982-08-25 Method for inhibiting mineralization of natural tissue during implantation

Publications (2)

Publication Number Publication Date
ES525136A0 true ES525136A0 (es) 1985-10-01
ES8600062A1 ES8600062A1 (es) 1985-10-01

Family

ID=23627945

Family Applications (1)

Application Number Title Priority Date Filing Date
ES525136A Expired ES8600062A1 (es) 1982-08-25 1983-08-24 Un metodo para inhibir la mineralizacion de un tejido natural

Country Status (6)

Country Link
US (1) US4405327A (es)
EP (1) EP0103946A3 (es)
JP (1) JPS5937945A (es)
BR (1) BR8303580A (es)
ES (1) ES8600062A1 (es)
ZA (1) ZA836278B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001879A1 (en) * 1982-11-12 1984-05-24 American Hospital Supply Corp Surfactant treatment of implantable biological tissue to inhibit calcification
US4885005A (en) * 1982-11-12 1989-12-05 Baxter International Inc. Surfactant treatment of implantable biological tissue to inhibit calcification
US5215541A (en) * 1982-11-12 1993-06-01 Baxter International Inc. Surfactant treatment of implantable biological tissue to inhibit calcification
JPS6075227A (ja) * 1983-09-29 1985-04-27 新田ゼラチン株式会社 シネレシスによるコラ−ゲン成形物の製造法
CA1254839A (en) * 1984-08-14 1989-05-30 Mark W. Torrianni Retarded mineralization of implantable tissue by surface active betaines
US4786287A (en) * 1986-10-10 1988-11-22 Baxter Travenol Laboratories Process for decreasing residual aldehyde levels in implantable bioprosthetic tissue
US4800603A (en) * 1987-01-30 1989-01-31 Jaffe Norman R Tissue fixation with vapor
US5746775A (en) * 1988-04-01 1998-05-05 The Board Of Regent6S Of The University Of Michigan Method of making calcification-resistant bioprosthetic tissue
JPH04503356A (ja) * 1989-02-17 1992-06-18 バクスター　インターナショナル　インコーポレーテッド 生充填移植片の石灰化軽減
US5192312A (en) * 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
US5476516A (en) * 1992-03-13 1995-12-19 Albert Einstein College Of Medicine Of Yeshiva University Anticalcification treatment for aldehyde-tanned biological tissue
US5437287A (en) * 1992-08-17 1995-08-01 Carbomedics, Inc. Sterilization of tissue implants using iodine
US5509932A (en) * 1993-04-08 1996-04-23 Keogh; James R. Fixed tissue medical devices comprising albumin-binding dyes
JPH09510108A (ja) * 1994-03-14 1997-10-14 クリオライフ，インコーポレイティド 移植用処理組織及び調製方法
US5595571A (en) * 1994-04-18 1997-01-21 Hancock Jaffe Laboratories Biological material pre-fixation treatment
CN1131913A (zh) * 1994-06-15 1996-09-25 圣·裘德医疗公司 增加天然组织的交联
US5931969A (en) * 1994-07-29 1999-08-03 Baxter International Inc. Methods and apparatuses for treating biological tissue to mitigate calcification
USRE40570E1 (en) 1994-07-29 2008-11-11 Edwards Lifesciences Corporation Apparatuses and methods for treating biological tissue to mitigate calcification
EP0804255B1 (en) * 1994-07-29 2001-10-04 Edwards Lifesciences Corporation Methods for treating implantable biological tissues to mitigate the calcification thereof
US5782931A (en) * 1996-07-30 1998-07-21 Baxter International Inc. Methods for mitigating calcification and improving durability in glutaraldehyde-fixed bioprostheses and articles manufactured by such methods
US5862806A (en) * 1997-10-30 1999-01-26 Mitroflow International, Inc. Borohydride reduction of biological tissues
US6008292A (en) * 1997-12-02 1999-12-28 Baxter International Inc. Method for inhibiting calcification of aldehyde-fixed bioprosthetic materials
US6394096B1 (en) 1998-07-15 2002-05-28 Corazon Technologies, Inc. Method and apparatus for treatment of cardiovascular tissue mineralization
US6527979B2 (en) * 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
US6214054B1 (en) 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
US6471723B1 (en) * 2000-01-10 2002-10-29 St. Jude Medical, Inc. Biocompatible prosthetic tissue
US6878168B2 (en) 2002-01-03 2005-04-12 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
US7579381B2 (en) * 2005-03-25 2009-08-25 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
CN103933612B (zh) 2006-10-27 2016-06-22 爱德华兹生命科学公司 用于外科植入的生物组织
US9101691B2 (en) 2007-06-11 2015-08-11 Edwards Lifesciences Corporation Methods for pre-stressing and capping bioprosthetic tissue
US8357387B2 (en) 2007-12-21 2013-01-22 Edwards Lifesciences Corporation Capping bioprosthetic tissue to reduce calcification
BR122014006918B1 (pt) 2010-03-23 2020-09-29 Edwards Lifesciences Corporation. Método para preparar material de membrana de tecido bioprotético
US8906601B2 (en) 2010-06-17 2014-12-09 Edwardss Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
CA2794135C (en) 2010-06-17 2018-01-02 Edwards Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
US9351829B2 (en) 2010-11-17 2016-05-31 Edwards Lifesciences Corporation Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
US9358107B2 (en) 2011-06-30 2016-06-07 Edwards Lifesciences Corporation Systems, dies, and methods for processing pericardial tissue
US10238771B2 (en) 2012-11-08 2019-03-26 Edwards Lifesciences Corporation Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
US9615922B2 (en) 2013-09-30 2017-04-11 Edwards Lifesciences Corporation Method and apparatus for preparing a contoured biological tissue
US10959839B2 (en) 2013-10-08 2021-03-30 Edwards Lifesciences Corporation Method for directing cellular migration patterns on a biological tissue
WO2018222434A1 (en) 2017-05-31 2018-12-06 Edwards Lifesciences Corporation Collagen fibers and articles formed therefrom
WO2019147585A1 (en) 2018-01-23 2019-08-01 Edwards Lifesciences Corporation Method for pre-stretching implantable biocompatible materials, and materials and devices produced thereby
WO2020092205A1 (en) 2018-11-01 2020-05-07 Edwards Lifesciences Corporation Transcatheter pulmonic regenerative valve
CN111701077B (zh) * 2020-06-24 2021-05-11 四川大学 一种具有抗血栓抗钙化功能的瓣膜及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966401A (en) * 1974-07-01 1976-06-29 Hancock Laboratories Incorporated Preparing natural tissue for implantation so as to provide improved flexibility
US4050893A (en) * 1974-07-22 1977-09-27 Hancock Laboratories, Inc. Arrangement for preparing natural tissue for implantation
US4323358A (en) * 1981-04-30 1982-04-06 Vascor, Inc. Method for inhibiting mineralization of natural tissue during implantation

Also Published As

Publication number Publication date
JPS5937945A (ja) 1984-03-01
ZA836278B (en) 1985-04-24
EP0103946A2 (en) 1984-03-28
BR8303580A (pt) 1984-04-24
ES8600062A1 (es) 1985-10-01
EP0103946A3 (en) 1985-03-27
US4405327A (en) 1983-09-20

Similar Documents

Publication Publication Date Title
ES525136A0 (es) Un metodo para inhibir la mineralizacion de un tejido natural
ES525137A0 (es) Un metodo de inhibicion de la mineralizacion del tejido natural
ES544775A0 (es) Un procedimiento para la preparacion de gem-diesteres gene- radores de peroxiacidos
MX7035E (es) Procedimiento para preparar 3-isoxazolidinona
ES554935A0 (es) Un procedimiento para la preparacion de pirazolo- y piridazo-pirazolinas, -piridazinas y -diacepinas
ES524823A0 (es) Un procedimiento para la preparacion de nuevas fenetanolaminas
MX155025A (es) Procedimiento para producir cefalosporinas
ES537440A0 (es) Un procedimiento para preparar 1-amino-4-nitro-acridinonas sustituidas
ES536469A0 (es) Procedimiento para preparar nuevas 1-bencil-aminoalquil-pirrolidinonas
ES502966A0 (es) Un procedimiento para la preparacion de almidones tratados
ES530461A0 (es) Procedimiento para preparar nuevos azoles
AR230995A1 (es) Procedimiento para producir n-fosfono-metilglicina
ES557649A0 (es) Un procedimiento para preparar un derivado de octahidrobenzo (f)quinoleina
DK507283A (da) Fodprotese
MX7717E (es) Un procedimiento para inhibir la mineralizacion de los tejidos naturales despues de su implantacion
AR240816A1 (es) Procedimiento para producir nuevos derivados de la cumarina
ES544119A0 (es) Procedimiento para preparar nuevos bencimidazoles
ES546090A0 (es) Proceso para preparar tejido implantable para retardar la mineralizacion.
ES544251A0 (es) Un procedimiento para la preparacion de benzoquinolicinas
ES523288A0 (es) Procedimiento para preparar un derivado de pirazolpiridina.
ES533289A0 (es) Un procedimiento para curtir pieles
ES546645A0 (es) Procedimiento para preparar un pseudooligosacarido
IT1160766B (it) Pelle artificiale
ES529879A0 (es) Un procedimiento para la preparacion de nuevos benzonitrilos
ES548235A0 (es) Procedimiento para preparar n6-benzopirano- y benzotiopira- no-adenosinas